Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"I have a doctor that handles all the other stuff." Perceptions of older adults with cancer about discussing aging-related conditions with their oncologists.

Journal of geriatric oncology·2024
Same author

An Unsupervised Machine Learning Approach to Evaluating the Association of Symptom Clusters With Adverse Outcomes Among Older Adults With Advanced Cancer: A Secondary Analysis of a Randomized Clinical Trial.

JAMA network open·2023
Same author

Caregiver-oncologist prognostic concordance, caregiving esteem, and caregiver outcomes.

Journal of geriatric oncology·2022
Same author

The shared uncertainty experience of older adults with advanced cancer and their caregivers.

Psycho-oncology·2022
Same author

PA- and NP-led Ommaya clinics to manage leptomeningeal carcinomatosis.

JAAPA : official journal of the American Academy of Physician Assistants·2021
Same author

Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants.

Genetics in medicine : official journal of the American College of Medical Genetics·2021

Related Experiment Videos

Breast cancer risk management.

Jennifer G Reeder1, Victor G Vogel

  • 1Division of Hematology/Oncology, University of Pittsburgh Medical Center Cancer Pavilion, PA 15232, USA. reederj2@upmc.edu

Clinical Breast Cancer
|February 14, 2008
PubMed
Summary

Selective estrogen receptor modulators (SERMs) like tamoxifen and raloxifene show promise for breast cancer prevention in high-risk women. While tamoxifen is effective, raloxifene offers a potentially safer alternative with fewer side effects.

Area of Science:

  • Oncology
  • Pharmacology
  • Preventive Medicine

Background:

  • Breast cancer affects numerous American women annually, with risk factors identifying high-risk individuals.
  • Chemoprevention strategies are being explored to prevent breast cancer in high-risk populations.
  • Selective estrogen receptor modulators (SERMs) are investigated for their estrogen antagonist effects in breast tissue.

Purpose of the Study:

  • To review clinical trials of tamoxifen and raloxifene for breast cancer chemoprevention.
  • To discuss the efficacy and side effect profiles of tamoxifen and raloxifene.
  • To propose a management strategy for breast cancer prevention in primary care.

Main Methods:

  • Review of clinical trials evaluating tamoxifen and raloxifene for breast cancer prevention.

Related Experiment Videos

  • Analysis of efficacy data, including reduction in breast cancer incidence.
  • Assessment of adverse events and quality of life impacts associated with these agents.

    • Main Results:

    • Tamoxifen demonstrated a 38% reduction in all breast cancers and a 48% reduction in ER-positive tumors.
    • Adverse events and perceived decline in quality of life are significant deterrents to tamoxifen use.
    • Raloxifene emerged as a potential alternative due to its efficacy and favorable safety profile, particularly in osteoporosis management.

    Conclusions:

    • Tamoxifen and raloxifene are established SERMs for breast cancer chemoprevention.
    • Balancing efficacy with side effect profiles is crucial for patient management.
    • A primary care-focused management strategy is needed for effective breast cancer risk reduction.